Sino Biopharmaceutical Ltd Stock Today
| SBHMY Stock | USD 9.05 0.00 0.00% |
Performance7 of 100
| Odds Of DistressLess than 9
|
Sino Biopharmaceutica is trading at 9.05 as of the 23rd of November 2024; that is No Change since the beginning of the trading day. The stock's open price was 9.05. Sino Biopharmaceutica has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat ok performance during the last 90 days. Equity ratings for Sino Biopharmaceutical Ltd are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 4th of December 2022 and ending today, the 23rd of November 2024. Click here to learn more.
Sino Biopharmaceutical Limited, an investment holding company, operates as a research and development pharmaceutical conglomerate in the Peoples Republic of China. The company was incorporated in 2000 and is headquartered in Wan Chai, Hong Kong. Sino Biopharmaceutica is traded on OTC Exchange in the United States.. The company has 940.69 M outstanding shares. More on Sino Biopharmaceutical Ltd
Moving against Sino Pink Sheet
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Sino Pink Sheet Highlights
| CEO, Executive Director | Ping Tse |
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Sino Biopharmaceutical Ltd [SBHMY] is a Pink Sheet which is traded between brokers as part of OTC trading. The company currently falls under 'Large-Cap' category with a current market capitalization of 10.88 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Sino Biopharmaceutica's market, we take the total number of its shares issued and multiply it by Sino Biopharmaceutica's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Sino Biopharmaceutical classifies itself under Healthcare sector and is part of Biotechnology industry. The entity has 940.69 M outstanding shares.
Sino Biopharmaceutical Ltd has accumulated about 15.67 B in cash with 5.37 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 16.96, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Sino Biopharmaceutica Probability Of Bankruptcy
Sino Biopharmaceutical Risk Profiles
| Mean Deviation | 0.9018 | |||
| Standard Deviation | 2.86 | |||
| Variance | 8.17 | |||
| Risk Adjusted Performance | 0.1073 |
Sino Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Sino Biopharmaceutica without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Holdings Now
Portfolio HoldingsCheck your current holdings and cash postion to detemine if your portfolio needs rebalancing |
| All Next | Launch Module |
Additional Tools for Sino Pink Sheet Analysis
When running Sino Biopharmaceutica's price analysis, check to measure Sino Biopharmaceutica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sino Biopharmaceutica is operating at the current time. Most of Sino Biopharmaceutica's value examination focuses on studying past and present price action to predict the probability of Sino Biopharmaceutica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sino Biopharmaceutica's price. Additionally, you may evaluate how the addition of Sino Biopharmaceutica to your portfolios can decrease your overall portfolio volatility.